Quick Answer
Milestone Pharmaceuticals Inc. reported Shares Outstanding of 106.24 million shares for fiscal year 2025.
Milestone Pharmaceuticals Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 106.24M | +99.1% |
| 2024 | 53.35M | +59.3% |
| 2023 | 33.48M | -2.3% |
| 2022 | 34.29M | +14.7% |
| 2021 | 29.90M | +0.2% |
| 2020 | 29.83M | +21.7% |
| 2019 | 24.51M | +4006.3% |
| 2018 | 596,787 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 85.17M | +59.7% | +59.2% |
| June 30, 2025 | 53.49M | +0.4% | +0.1% |
| March 31, 2025 | 53.46M | +0.4% | +0.2% |
| December 31, 2024 | 53.35M | +59.3% | +0.0% |
| September 30, 2024 | 53.33M | +59.3% | +0.1% |
| June 30, 2024 | 53.27M | +59.7% | +0.0% |
| March 31, 2024 | 53.25M | +59.7% | +59.0% |
| December 31, 2023 | 33.48M | -2.3% | +0.0% |
- Milestone Pharmaceuticals Inc. showed an increase of +99.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Milestone Pharmaceuticals Inc.’s shares outstanding has grown by 17701.4% (from 596.8 thousand shares to 106.24 million shares).
- The most recent figure is from Milestone Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: